A new multi-direction DWI sequence, the latest Swoop® system software, and the first advancement in Hyperfine’s Optive AI™ software, delivers clearer, higher-quality images for stroke diagnosis, ...
Successful investing is about anticipating others' anticipation. The value of a stock is based on what people think it's worth. Selling shares of Hyperfine may be a great opportunity for buyers. One ...
Hyperfine Research Inc. has joined with Penn Medicine in a clinical research study of the world's first portable, low-cost magnetic resonance imaging (MRI) system. This collaboration will examine the ...
Hyperfine Announces FDA Clearance of a New Next-Generation Swoop® System Powered by Optive AI™ Software, Delivering a Transformative Leap in Image Quality This major Swoop® system scanner redesign and ...
GUILFORD, Conn. - Hyperfine, Inc. (NASDAQ:HYPR) has received FDA clearance for a new multi-direction diffusion-weighted imaging (DWI) software sequence for its Swoop portable MRI system, the company ...
Following the recent clearance of the new Swoop® System, two leading hospitals in the United States have purchased the first commercial units, marking the launch of next-generation portable MR brain ...
Hyperfine Announces FDA Clearance of the First Optive AI™ Software Update with Advanced Diffusion Imaging Capability, Focused on Enhancing Stroke Detection with the Swoop® System A new multi-direction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results